Autologous stem cell transplantation is still a valid option in good- and intermediate-risk AML: a GITMO survey on 809 patients autografted in first complete remission

F. Saraceni; B. Bruno; Roberto Massimo Lemoli; Giovanna Meloni; William Arcese; M. Falda; Fabio Ciceri; Emilio Paolo Alessandrino; Giorgina Specchia; Rosanna Scimè; Roberto Raimondi; A. Bacigalupo; Alberto Bosi; F. Onida; Alessandro Rambaldi; F. Bonifazi; A. Olivieri

doi:10.1038/bmt.2016.233

Autologous stem cell transplantation is still a valid option in good- and intermediate-risk AML: a GITMO survey on 809 patients autografted in first complete remission

F. Saraceni, B. Bruno, Roberto Massimo Lemoli, Giovanna Meloni, William Arcese, M. Falda, Fabio Ciceri, Emilio Paolo Alessandrino, Giorgina Specchia, Rosanna Scimè, Roberto Raimondi, A. Bacigalupo, Alberto Bosi, F. Onida, Alessandro Rambaldi, F. Bonifazi, A. Olivieri

Research output: Contribution to journal › Article › peer-review

Original language	English
Journal	Bone Marrow Transplantation
DOIs	https://doi.org/10.1038/bmt.2016.233
Publication status	Accepted/In press - Sep 26 2016

ASJC Scopus subject areas

Hematology
Transplantation

Access to Document

10.1038/bmt.2016.233

Cite this

Saraceni, F., Bruno, B., Lemoli, R. M., Meloni, G., Arcese, W., Falda, M., Ciceri, F., Alessandrino, E. P., Specchia, G., Scimè, R., Raimondi, R., Bacigalupo, A., Bosi, A., Onida, F., Rambaldi, A., Bonifazi, F., & Olivieri, A. (Accepted/In press). Autologous stem cell transplantation is still a valid option in good- and intermediate-risk AML: a GITMO survey on 809 patients autografted in first complete remission. Bone Marrow Transplantation. https://doi.org/10.1038/bmt.2016.233

Autologous stem cell transplantation is still a valid option in good- and intermediate-risk AML : a GITMO survey on 809 patients autografted in first complete remission. / Saraceni, F.; Bruno, B.; Lemoli, Roberto Massimo; Meloni, Giovanna; Arcese, William; Falda, M.; Ciceri, Fabio; Alessandrino, Emilio Paolo; Specchia, Giorgina; Scimè, Rosanna; Raimondi, Roberto; Bacigalupo, A.; Bosi, Alberto; Onida, F.; Rambaldi, Alessandro; Bonifazi, F.; Olivieri, A.

In: Bone Marrow Transplantation, 26.09.2016.

Research output: Contribution to journal › Article › peer-review

Saraceni, F, Bruno, B, Lemoli, RM, Meloni, G, Arcese, W, Falda, M, Ciceri, F, Alessandrino, EP, Specchia, G, Scimè, R, Raimondi, R, Bacigalupo, A, Bosi, A, Onida, F, Rambaldi, A, Bonifazi, F & Olivieri, A 2016, 'Autologous stem cell transplantation is still a valid option in good- and intermediate-risk AML: a GITMO survey on 809 patients autografted in first complete remission', Bone Marrow Transplantation. https://doi.org/10.1038/bmt.2016.233

Saraceni, F. ; Bruno, B. ; Lemoli, Roberto Massimo ; Meloni, Giovanna ; Arcese, William ; Falda, M. ; Ciceri, Fabio ; Alessandrino, Emilio Paolo ; Specchia, Giorgina ; Scimè, Rosanna ; Raimondi, Roberto ; Bacigalupo, A. ; Bosi, Alberto ; Onida, F. ; Rambaldi, Alessandro ; Bonifazi, F. ; Olivieri, A. / Autologous stem cell transplantation is still a valid option in good- and intermediate-risk AML : a GITMO survey on 809 patients autografted in first complete remission. In: Bone Marrow Transplantation. 2016.

@article{a8fc732a84174fa68e06548bc6a1c22b,

title = "Autologous stem cell transplantation is still a valid option in good- and intermediate-risk AML: a GITMO survey on 809 patients autografted in first complete remission",

author = "F. Saraceni and B. Bruno and Lemoli, {Roberto Massimo} and Giovanna Meloni and William Arcese and M. Falda and Fabio Ciceri and Alessandrino, {Emilio Paolo} and Giorgina Specchia and Rosanna Scim{\`e} and Roberto Raimondi and A. Bacigalupo and Alberto Bosi and F. Onida and Alessandro Rambaldi and F. Bonifazi and A. Olivieri",

year = "2016",

month = sep,

day = "26",

doi = "10.1038/bmt.2016.233",

language = "English",

journal = "Bone Marrow Transplantation",

issn = "0268-3369",

publisher = "Nature Publishing Group",

}

TY - JOUR

T1 - Autologous stem cell transplantation is still a valid option in good- and intermediate-risk AML

T2 - a GITMO survey on 809 patients autografted in first complete remission

AU - Saraceni, F.

AU - Bruno, B.

AU - Lemoli, Roberto Massimo

AU - Meloni, Giovanna

AU - Arcese, William

AU - Falda, M.

AU - Ciceri, Fabio

AU - Alessandrino, Emilio Paolo

AU - Specchia, Giorgina

AU - Scimè, Rosanna

AU - Raimondi, Roberto

AU - Bacigalupo, A.

AU - Bosi, Alberto

AU - Onida, F.

AU - Rambaldi, Alessandro

AU - Bonifazi, F.

AU - Olivieri, A.

PY - 2016/9/26

Y1 - 2016/9/26

UR - http://www.scopus.com/inward/record.url?scp=84988733129&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84988733129&partnerID=8YFLogxK

U2 - 10.1038/bmt.2016.233

DO - 10.1038/bmt.2016.233

M3 - Article

JO - Bone Marrow Transplantation

JF - Bone Marrow Transplantation

SN - 0268-3369

ER -

Autologous stem cell transplantation is still a valid option in good- and intermediate-risk AML: a GITMO survey on 809 patients autografted in first complete remission

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this